Qiagen (QGEN) News Today $42.30 +0.32 (+0.76%) As of 03:58 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Qiagen (QGEN) Target Price Reduced Amid Negative Market Sentiment | QGEN Stock NewsApril 14 at 11:12 AM | gurufocus.comQiagen (NYSE:QGEN) Stock Price Up 2.2% - Still a Buy?Qiagen (NYSE:QGEN) Stock Price Up 2.2% - Here's What HappenedApril 9, 2025 | marketbeat.comQiagen (NYSE:QGEN) Issues FY25 Earnings GuidanceQiagen (NYSE:QGEN) updated its FY25 earnings guidance. The company provided EPS guidance of ~$2.35 for the period, compared to the consensus estimate of $2.27.April 9, 2025 | marketbeat.comQiagen (NYSE:QGEN) Issues Q1 Earnings GuidanceQiagen (NYSE:QGEN) updated its first quarter earnings guidance. The company provided EPS guidance of at least $0.55 for the period, compared to the consensus estimate of $0.49. The company also issued revenue guidance of $483 millionillion, compared to the consensus estimate of $464.42 millionillion.April 9, 2025 | marketbeat.comQiagen (NYSE:QGEN) Releases Q1 2025 Earnings GuidanceQiagen (NYSE:QGEN) updated its first quarter 2025 earnings guidance. The company provided EPS guidance of 0.550- for the period, compared to the consensus estimate of 0.490. The company also issued revenue guidance of $483.0 millionillion-, compared to the consensus estimate of $464.8 millionillion.April 9, 2025 | marketbeat.comQiagen (NYSE:QGEN) Issues FY 2025 Earnings GuidanceQiagen (NYSE:QGEN) updated its FY 2025 earnings guidance. The company provided EPS guidance of 2.350- for the period, compared to the consensus estimate of 2.290.April 9, 2025 | marketbeat.comQiagen Announces Change in Total Voting RightsApril 9, 2025 | tipranks.comJefferies Remains a Buy on Qiagen (QGEN)April 8, 2025 | markets.businessinsider.comQIAGEN N.V. to Release Results for Q1 2025 and Hold WebcastApril 8, 2025 | businesswire.comQiagen Shares Rise After Guidance LiftApril 7, 2025 | marketwatch.comQiagen gains after guidance raiseApril 7, 2025 | msn.comQiagen Shares Rise Premarket As Preliminary Q1 Results, Hikes FY25 EPS GuidanceApril 7, 2025 | benzinga.comTD Cowen Keeps Their Hold Rating on Qiagen (QGEN)April 7, 2025 | markets.businessinsider.comQiagen NV Announces Strong Q1 2025 Results and Updates Full-Year Earnings OutlookApril 6, 2025 | gurufocus.comEQS-Adhoc: QIAGEN N.V.: QIAGEN announces strong preliminary Q1 2025 results and updates full-year 2025 adjusted earnings per share outlookApril 6, 2025 | markets.businessinsider.comQiagen NV (QGEN) Exceeds Q1 2025 Financial ExpectationsApril 6, 2025 | gurufocus.comQIAGEN Delivers Strong Preliminary Q1 2025 Results Exceeding Outlook and Raises Full-Year 2025 Adjusted EPS OutlookApril 6, 2025 | businesswire.comQiagen (NYSE:QGEN) Lowered to "Neutral" Rating by Redburn AtlanticRedburn Atlantic downgraded Qiagen from a "buy" rating to a "neutral" rating in a report on Friday.April 6, 2025 | marketbeat.comQiagen (NYSE:QGEN) Downgraded to Neutral Rating by Redburn AtlanticApril 6, 2025 | americanbankingnews.comQiagen (NYSE:QGEN) Shares Gap Up - Here's What HappenedQiagen (NYSE:QGEN) Shares Gap Up - Time to Buy?April 5, 2025 | marketbeat.comQiagen downgraded to Neutral from Buy at Redburn AtlanticApril 5, 2025 | markets.businessinsider.comRedburn Atlantic Downgrades Qiagen N.V. (QGEN)April 5, 2025 | msn.comQiagen Announces Voting Rights Update with Bank of AmericaApril 4, 2025 | tipranks.comQIAGEN N.V.: QIAGEN Launches QIAprep& Plasmodium Kit to Strengthen Malaria Research and Surveillance EffortsApril 1, 2025 | finanznachrichten.deQIAGEN Launches QIAprep& Plasmodium Kit to Strengthen Malaria Research and Surveillance EffortsApril 1, 2025 | finance.yahoo.comQiagen NV Launches Innovative QIAprep& Plasmodium Kit for Malaria ResearchApril 1, 2025 | gurufocus.comQIAGEN Launches QIAprep& Plasmodium Kit to Strengthen Malaria Research and Surveillance EffortsApril 1, 2025 | businesswire.comQiagen (NYSE:QGEN) Short Interest UpdateQiagen (NYSE:QGEN - Get Free Report) saw a significant increase in short interest in March. As of March 15th, there was short interest totalling 3,720,000 shares, an increase of 40.4% from the February 28th total of 2,650,000 shares. Based on an average trading volume of 1,140,000 shares, the short-interest ratio is currently 3.3 days. Approximately 1.7% of the company's shares are short sold.March 31, 2025 | marketbeat.comQIAGEN Announces Form 20-F Annual Report Filing for 2024 ResultsMarch 31, 2025 | gurufocus.comQiagen NV (QGEN) Files 2024 Annual Report with SECMarch 31, 2025 | gurufocus.comQIAGEN Announces Form 20-F Annual Report Filing for 2024 ResultsMarch 31, 2025 | finance.yahoo.comJefferies Keeps Their Buy Rating on Qiagen (QGEN)March 30, 2025 | markets.businessinsider.com🌱 Iovance Biotherapeutics' promising stock potentialMarch 29, 2025 | msn.comAre Qiagen N.V.'s (NYSE:QGEN) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?March 28, 2025 | finance.yahoo.comQiagen (NYSE:QGEN) Receives Average Rating of "Hold" from BrokeragesQiagen (NYSE:QGEN - Get Free Report) has received a consensus recommendation of "Hold" from the ten brokerages that are currently covering the company, Marketbeat reports. Seven analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 1-yearMarch 25, 2025 | marketbeat.comInteresting QGEN Call Options For November 21stMarch 22, 2025 | nasdaq.comQiagen (NYSE:QGEN) Sees Large Decline in Short InterestQiagen (NYSE:QGEN - Get Free Report) was the target of a large drop in short interest during the month of February. As of February 28th, there was short interest totalling 2,650,000 shares, a drop of 16.1% from the February 13th total of 3,160,000 shares. Approximately 1.2% of the company's shares are short sold. Based on an average daily volume of 1,120,000 shares, the short-interest ratio is currently 2.4 days.March 19, 2025 | marketbeat.comThe past three-year earnings decline for Qiagen (NYSE:QGEN) likely explains shareholders long-term lossesMarch 8, 2025 | finance.yahoo.comQiagen (QGEN) Down 6% Since Last Earnings Report: Can It Rebound?March 7, 2025 | msn.comQiagen (NYSE:QGEN) Sees Large Increase in Short InterestQiagen (NYSE:QGEN - Get Free Report) was the target of a significant growth in short interest in February. As of February 15th, there was short interest totalling 3,160,000 shares, a growth of 23.9% from the January 31st total of 2,550,000 shares. Approximately 1.5% of the company's stock are short sold. Based on an average daily volume of 1,060,000 shares, the short-interest ratio is presently 3.0 days.March 7, 2025 | marketbeat.comQiagen (NYSE:QGEN) Reaches New 12-Month Low - Should You Sell?Qiagen (NYSE:QGEN) Hits New 12-Month Low - Here's WhyMarch 6, 2025 | marketbeat.comQiagen announces FDA clearance for QIAstat-Dx Gastrointestinal Panel 2 Mini BMarch 6, 2025 | markets.businessinsider.comQiagen NV (QGEN) Secures FDA Clearance for New Gastrointestinal PanelMarch 6, 2025 | gurufocus.comQIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolioMarch 6, 2025 | businesswire.comQiagen Announces Managerial Transaction Involving Restricted Stock UnitsMarch 4, 2025 | tipranks.comQiagen Announces Manager’s Transaction Involving Restricted Stock UnitsMarch 4, 2025 | tipranks.comQiagen Announces Managerial Stock TransactionsMarch 4, 2025 | tipranks.comQiagen Announces Managerial Stock Unit GrantMarch 4, 2025 | tipranks.comQiagen N.V. (QGEN): Among the Cash-Rich Mid Cap Stocks to Buy NowMarch 4, 2025 | uk.finance.yahoo.comQIAGEN Files Patent Complaint Against BioMérieux To Protect QuantiFERON TechnologyMarch 4, 2025 | nasdaq.com Remove Ads Get Qiagen News Delivered to You Automatically Sign up to receive the latest news and ratings for QGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address QGEN Media Mentions By Week QGEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. QGEN News Sentiment▼0.321.00▲Average Medical News Sentiment QGEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. QGEN Articles This Week▼117▲QGEN Articles Average Week Remove Ads Get Qiagen News Delivered to You Automatically Sign up to receive the latest news and ratings for QGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ARGX News ONC News BNTX News TEVA News ITCI News SMMT News GMAB News RDY News MRNA News VTRS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:QGEN) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersThe biggest story CNBC isn't talking about (yet)This Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredIf Gold Is ‘Stalling,’ Why Are Banks Hoarding Billions In Secret?Prosperity was something every American family could build, protect, and pass down. Because that's what legacy...Colonial Metals | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredDeFi Coin on Verge of Breakout!Crypto’s down — but the fundamentals aren’t. Strategic investors are using this dip to scoop up undervalued...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Qiagen Please log in to your account or sign up in order to add this asset to your watchlist. Share Qiagen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy QGEN Stock Free QGEN Stock Alerts